Bal Pharma Consolidated December 2022 Net Sales at Rs 76.62 crore, up 10.77% Y-o-Y

Vineet Laboratories Ltd, Bal Pharma Ltd, Prajay Engineers Syndicate Ltd and Gyscoal Alloys Ltd are among the other gainers in the BSE’s ‘B’ group today, 21 December 2022.

Balkrishna Paper Mills Ltd leads gainers in ‘B’ group

Salona Cotspin Ltd, Dynacons Systems & Solutions Ltd, Birla Cable Ltd and Bal Pharma Ltd are among the other gainers in the BSE’s ‘B’ group today, 23 February 2022.

Yaari Digital Integrated Services Ltd leads gainers in ‘B’ group

IFB Agro Industries Ltd, Bal Pharma Ltd, Indo Tech Transformers Ltd and Poojawestern Metaliks Ltd are among the other gainers in the BSE’s ‘B’ group today, 20 January 2022.

Intense Technologies Ltd leads gainers in ‘B’ group

Essar Shipping Ltd, Oriental Trimex Ltd, Swelect Energy Systems Ltd and Bal Pharma Ltd are among the other losers in the BSE’s ‘B’ group today, 04 January 2022.

MSP Steel & Power Ltd leads losers in ‘B’ group

Inventure Growth & Securities Ltd, ARSS Infrastructure Projects Ltd, T T Ltd and Bal Pharma Ltd are among the other gainers in the BSE’s ‘B’ group today, 03 January 2022.

Shree Rama Multi-Tech Ltd leads gainers in ‘B’ group

The rating has been reaffirmed on long-term fund-based facilities at ICRA BB+ and short-term rating at ICRA A4+.

ICRA upgrades credit rating outlook of Bal Pharma from Stable to Positive; Stock soars 3%

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

Top stocks in focus: Metro Brands, Visagar Polytex, India Cements, IndiaMART, Bal Pharma

Stocks In News: Check out the companies making the biggest headlines before the opening bell.

Buzzing Stocks: ZEE, Metro Brands, India Cements, IRB Infra, Bal Pharma And Others In News

Bal Pharma Consolidated September 2021 Net Sales At Rs 67.17 Crore, Up 4.05% Y-o-Y

Bal Pharma standalone net profit rises 99.35% in the September 2021 quarter

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Bal Pharma Limited is engaged in the manufacture and sale of pharmaceutical products. The Company’s business comprises of Active Pharmaceutical Ingredients (API), Finished Formulations, Ayurvedic, Research and Development.

Bal Pharma Ltd